Imperial College London

Emeritus ProfessorKimFox

Faculty of MedicineNational Heart & Lung Institute

Emeritus Professor
 
 
 
//

Contact

 

+44 (0)20 7594 7966kim.fox

 
 
//

Assistant

 

Ms Deborah Curcher +44 (0)20 7594 7966

 
//

Location

 

Guy Scadding BuildingRoyal Brompton Campus

//

Summary

 

Publications

Publication Type
Year
to

565 results found

Bertrand ME, Fox KM, Remme WJ, Ferrari R, Simoons MLet al., 2009, Angiotensin-converting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revascularization: A subgroup analysis of the EUROPA trial, ARCHIVES OF CARDIOVASCULAR DISEASES, Vol: 102, Pages: 89-96, ISSN: 1875-2136

Journal article

de Werf FV, Bax J, Betriu A, Blomstrom-Lunqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis Met al., 2009, Proceeding in acute myocardial infraction with persistent non-ST segment elevation., KARDIOLOGIA POLSKA, Vol: 67, Pages: S53-S98, ISSN: 0022-9032

Journal article

Ferrari R, Fox K, 2009, Insight into the Mode of Action of ACE Inhibition in Coronary Artery Disease The Ultimate 'EUROPA' Story, DRUGS, Vol: 69, Pages: 265-277, ISSN: 0012-6667

Journal article

Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici M, Mattle HP, Rothwell PMet al., 2009, The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study: Baseline Characteristics of the Population, CEREBROVASCULAR DISEASES, Vol: 27, Pages: 608-613, ISSN: 1015-9770

Journal article

Fox K, Ford I, Steg PG, Tendera M, Ferrari Ret al., 2008, Ivabradine in heart failure: what about digoxin? Reply, LANCET, Vol: 372, Pages: 2113-2114, ISSN: 0140-6736

Journal article

Kristensen SD, Baumgartner H, Casadei B, Drexler H, Eeckhout E, Filippatos G, Fox KAA, Perk J, Pierard LA, Poldermans D, Schunkert H, Vardas PE, van der Wall EE, Fox K, Bax JJet al., 2008, Highlights of the 2008 Scientific Sessions of the European Society of Cardiology Munich, Germany, August 30 to September 3, 2008., J Am Coll Cardiol, Vol: 52, Pages: 2032-2042

Journal article

Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Silber S, Aguirre FV, Al-Attar N, Alegria E, Andreotti F, Benzer W, Breithardt O, Danchin N, Mario CD, Dudek D, Gulba D, Halvorsen S, Kaufmann P, Kornowski R, Lip GYH, Rutten Fet al., 2008, Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation, EUROPEAN HEART JOURNAL, Vol: 29, Pages: 2909-2945, ISSN: 0195-668X

Journal article

Turnbull F, Woodward M, Neal B, Barzi F, Ninomiya T, Chalmers J, Perkovic V, Li N, MacMahon Set al., 2008, Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials, EUROPEAN HEART JOURNAL, Vol: 29, Pages: 2669-2680, ISSN: 0195-668X

Journal article

Brugts JJ, de Maat M, Boersma E, Witteman J, Uitterlinden A, Danser J, Remme W, Fox K, Simoons MLet al., 2008, Strong and Independent Association between Angiotensinogen Gene Polymorphisms and Hypertension in 10060 Patients with Stable Coronary Artery Disease, 81st Annual Scientific Session of the American-Heart-Association, Publisher: LIPPINCOTT WILLIAMS & WILKINS, Pages: S729-S729, ISSN: 0009-7322

Conference paper

Brugts JJ, Boersma E, Deckers JW, Remme W, Bertrand M, Fox K, Ferrari R, Simoons MLet al., 2008, The Treatment Effect of Perindopril is Consistent in All Patients with Vascular Disease or High Risk of Vascular Disease: A Combined Analysis of Three Perindopril Trials, 81st Annual Scientific Session of the American-Heart-Association, Publisher: LIPPINCOTT WILLIAMS & WILKINS, Pages: S1138-S1138, ISSN: 0009-7322

Conference paper

Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari Ret al., 2008, Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial, LANCET, Vol: 372, Pages: 817-821, ISSN: 0140-6736

Journal article

Fox K, Ford I, Steg PG, Tendera M, Ferrari Ret al., 2008, Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial, LANCET, Vol: 372, Pages: 807-816, ISSN: 0140-6736

Journal article

Brugts JJ, De Maat MPM, Boersma E, Danser AHJ, Remme W, Ferrari R, Fox K, Simoons MLet al., 2008, Functional polymorphisms in the angiotensinogen gene are associated with hypertension in patients with stable coronary artery disease, EUROPEAN HEART JOURNAL, Vol: 29, Pages: 102-103, ISSN: 0195-668X

Journal article

Brugts JJ, De Maat MPM, Boersma E, Witteman JCM, Uitterlinden AG, Danser J, Remme W, Ferrari R, Fox K, Simoons MLet al., 2008, Promotor polymorphisms of the angiotensinogen gene are associated with hypertension in patients with stable CAD, EUROPEAN HEART JOURNAL, Vol: 29, Pages: 658-658, ISSN: 0195-668X

Journal article

Brugts JJ, Boersma E, Deckers JW, Remme W, Bertrand M, Ferrari R, Fox K, Simoons MLet al., 2008, Consistent treatment effect of perindopril in patients with vascular disease or high risk of vascular disease: A combined analysis of three perindopril trials, EUROPEAN HEART JOURNAL, Vol: 29, Pages: 602-602, ISSN: 0195-668X

Journal article

Fox K, 2008, Benefits of perindopril all along the cardiovascular continuum: the level of evidence, EUROPEAN HEART JOURNAL SUPPLEMENTS, Vol: 10, Pages: G4-G12, ISSN: 1520-765X

Journal article

Daly C, Tavazzi L, Fox K, 2008, Inadequate control of heart rate in patients with stable angina: results from the European Heart Survey, EUROPEAN HEART JOURNAL, Vol: 29, Pages: 204-205, ISSN: 0195-668X

Journal article

de Silva R, Fox K, 2008, Early intervention in acute coronary syndrome: is bivalirudin monotherapy an effective antithrombotic strategy?, NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, Vol: 5, Pages: 308-309, ISSN: 1743-4297

Journal article

Daly CA, Stepinska J, Deptuch T, Ruzyllo W, Fox K, Gitt A, Tendera M, Fox Ket al., 2008, Differences in presentation and management of stable angina from east to west in Europe: A comparison between Poland and the UK, INTERNATIONAL JOURNAL OF CARDIOLOGY, Vol: 125, Pages: 311-318, ISSN: 0167-5273

Journal article

Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Sendon JLL, Steg PG, Tardif J-C, Tavazzi L, Tendera Met al., 2008, Resting heart rate and cardiovascular disease: The beta-blocker-hypertension paradox - Reply, JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol: 51, Pages: 331-332, ISSN: 0735-1097

Journal article

Ferrari R, Ford I, Fox K, Steg PG, Tendera M, BEAUTIFUL Study Grpet al., 2008, The BEAUTIFUL study: Randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction baseline characteristics of the study population, CARDIOLOGY, Vol: 109, Pages: 271-282, ISSN: 0008-6312

Objectives: Ivabradine is a selective heart rate-lowering agent that acts by inhibiting the pacemaker current I-f in sinoatrial node cells. Patients with coronary artery disease and left ventricular dysfunction are at high risk of death and cardiac events, and the BEAUTIFUL study was designed to evaluate the effects of ivabradine on outcome in such patients receiving optimal medical therapy. This report describes the study population at baseline. Methods: BEAUTIFUL is an international, multicentre, randomized, double-blind trial to compare ivabradine with placebo in reducing mortality and cardiovascular events in patients with stable coronary artery disease and left ventricular systolic dysfunction (ejection fraction <40%). Results: A total of 10,917 patients were randomized. At baseline, their mean age was 65 years, 83% were male, 98% Caucasian, 88% had previous myocardial infarction, 37% had diabetes, and 40% had metabolic syndrome. Mean ejection fraction was 32% and resting heart rate was 71.6 bpm. Concomitant medications included beta-blockers (87%), renin-angiotensin system agents (89%), antithrombotic agents (94%), and lipid-lowering agents (76%). Conclusions: Main results from BEAUTIFUL are expected in 2008, and should show whether ivabradine, on top of optimal medical treatment, reduces mortality and cardiovascular events in this population of high-risk patients. Copyright (c) 2007 S. Karger AG, Basel.

Journal article

Fox K, Recena JB, Garcia-Aranda VL, Valderrama JC, Alonso LFI, Calvar ASR, Aviles FF, Villa FP, Cortada JB, Alvarez RF, Peiro FN, Iglesias FC, Toral BS, Bescos LL, De Burgos FG, Casado RS, Galve E, Garcia GC, Dellborg M, Herlitz J, Ullman B, Blomgren J, Bandh S, Oehlin H, Dubach P, Gallino A, Hess O, Moccetti T, Eeckhout E, Vontobel H, Delabays A, Erol K, Kozan O, Mutlu B, Ergene O, Acarturk E, Yilmaz H, Ural D, Parkhomenko O, Polyvoda S, Dyadyk A, Vatutin M, Karpenko O, Kubyshkin V, Rudenko L, Putintsev V, Krayz I, Kovalsky I, Rudyk Y, Yurlov V, Mostovoy Y, Rishko M, Barna O, Slyvka Y, Perepelytsya M, Seredyuk N, Bazylevych A, Glushko L, Tashchuk V, Girina O, Vizir V, Pertseva T, Vlasenko M, Goloborodko B, Kolomiets S, Dzyak G, Sharuk O, Storozhuk B, Kovalenko V, Khomazyuk T, Soldatchenko S, Lutay M, Zharinov O, Serkova V, Korkushko O, Korzh O, Netyazhenko V, Sakharchuk I, Stadnyuk L, Bereznyakov I, Semidotska Z, Kolchin Y, Voronkov L, Tseluyko V, Amosova K, Batushkin V, Hall A, Lindsay S, Moriarty A, Kadr H, Francis CM, Saltissi S, Rozkovec A, Groves P, Crook JR, Purvis J, Brooksby P, Stewart M, Dutka D, Timmis A, Baig MW, Brady A, Williams S, Brooks N, Greaves Ket al., 2008, The BEAUTIFUL study:: Randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction baseline characteristics of the study population, CARDIOLOGY, Vol: 110, Pages: 271-282, ISSN: 0008-6312

Journal article

Fox K, Steg PG, 2008, Elevated heart rate proven to increase coronary events., Cardiovasc J Afr, Vol: 19, Pages: 276-278, ISSN: 1995-1892

Journal article

Kristensen SD, Baumgartner H, Drexler H, Eeckhout E, Filippatos G, Gitt AK, Linde C, Pierard LA, Poldermans D, Schunkert H, Sipido KR, van der Wall EE, Fox K, Bax JJ, European Society of Cardiologyet al., 2007, Highlights of the 2007 scientific sessions of the European Society of Cardiology Vienna, Austria, September 1-5, 2007., J Am Coll Cardiol, Vol: 50, Pages: 2421-2430

Journal article

Thygesen K, Alpert JS, White HD, Joint ESCACCFAHAWHF Task Force for the Redefinition of Myocardial Infarction, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand J-P, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon J-L, Pais P, Mendis S, Zhu J-R, Wallentin LC, Fernández-Avilés F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki L-M, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar Net al., 2007, Universal definition of myocardial infarction., Circulation, Vol: 116, Pages: 2634-2653

Journal article

Brugts JJ, Boersma E, Chonchol M, Deckers JW, Bertrand M, Remme WJ, Ferrari R, Fox K, Simoons MLet al., 2007, The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency, JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol: 50, Pages: 2148-2155, ISSN: 0735-1097

Journal article

Daly CA, Hildebrandt P, Bertrand M, Ferrari R, Remme W, Simoons M, Fox KMet al., 2007, Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial, HEART, Vol: 93, Pages: 1406-1411, ISSN: 1355-6037

Journal article

Brugts JJ, Boersma E, Chonchoi M, Deckers J, Remme W, Bertrand M, Ferrari R, Fox K, Simoons Met al., 2007, The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: Results from the Europa-trial, 80th Annual Scientific Session of the American-Heart-Association, Publisher: LIPPINCOTT WILLIAMS & WILKINS, Pages: 783-783, ISSN: 0009-7322

Conference paper

Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Better GA, Bonow R, Van Der Wall EE, Bassand J-P, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Senclon J-L, Pais P, MenclisT S, Zhu J-R, Wallentin LC, Fernandez-Aviles F, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki L-Met al., 2007, Universal definition of myocardial infarction, EUROPEAN HEART JOURNAL, Vol: 28, Pages: 2525-2538, ISSN: 0195-668X

Journal article

This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.

Request URL: http://wlsprd.imperial.ac.uk:80/respub/WEB-INF/jsp/search-html.jsp Request URI: /respub/WEB-INF/jsp/search-html.jsp Query String: id=00306427&limit=30&person=true&page=7&respub-action=search.html